JPMorgan downgraded Imprivata (NYSE: IMPR) from Overweight to Neutral with a price target of $19.00 (from $24.00).

For an analyst ratings summary and ratings history on Imprivata click here. For more ratings news on Imprivata click here.

Shares of Imprivata closed at $17.31 yesterday.